Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Are all beta-blockers the same for chronic heart failure?

S S Gottlieb1

  • 1Division of Cardiology, University of Maryland Medical Systems, 22 South Greene Street, Baltimore, MD 21201, USA. sgottlie@medicine.umaryland.edu

Current Cardiology Reports
|February 15, 2001
PubMed
Summary

Beta-blockers significantly improve survival and reduce hospitalizations in heart failure patients. These benefits are seen across diverse patient groups, with specific drugs like bisoprolol, metoprolol, and carvedilol showing marked advantages.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of nesiritide in patients with acute decompensated heart failure.

The New England journal of medicine·2011
Same author

Quality of life and psychological status of patients with implantable cardioverter defibrillators.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2007
Same author

Renal effects of adenosine A1-receptor antagonists in congestive heart failure.

Drugs·2001
Same author

Exercise in the geriatric patient with congestive heart failure.

The American journal of geriatric cardiology·2001
Same author

Comparative effects of three beta blockers (atenolol, metoprolol, and propranolol) on survival after acute myocardial infarction.

The American journal of cardiology·2001
Same author

Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failure.

Journal of cardiac failure·2001

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Beta-adrenergic receptor blockade is a cornerstone therapy for heart failure.
  • Established beta-blockers demonstrably improve survival and reduce morbidity in heart failure patients.
  • Benefits include decreased hospitalization rates and improved patient well-being.

Purpose of the Study:

  • To summarize the established benefits of beta-blockers in heart failure management.
  • To highlight the efficacy of commonly used beta-blockers such as bisoprolol, metoprolol, and carvedilol.
  • To note the limited efficacy of investigational agents like bucindolol and the unknown significance of drug-specific properties.

Main Methods:

  • Review of clinical trial data and established medical literature on beta-blocker therapy in heart failure.
  • Comparative analysis of survival and morbidity outcomes for different beta-blockers.

Related Experiment Videos

  • Identification of key pharmacological differences between beta-blockers.

    • Main Results:

    • Bisoprolol, metoprolol, and carvedilol have consistently demonstrated significant benefits in heart failure patients.
    • Beta-blocker therapy leads to increased survival and reduced hospitalization rates.
    • Bucindolol showed only marginal survival benefits in heart failure.

    Conclusions:

    • Beta-blocker therapy is essential for improving outcomes in heart failure.
    • Specific agents like bisoprolol, metoprolol, and carvedilol are highly effective.
    • Further research is needed to understand the clinical implications of differing beta-selectivity and vasodilation properties among beta-blockers.